Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Handforth

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Harmaline-induced tremor as a potential preclinical screening method for essential tremor medicationsFredricka C Martin, Anh Thu Le, Adrian Handforth
Epilepsy Research|October 8, 2003
Right-sided vagus nerve stimulation reduces generalized seizure severity in rats as effectively as left-sidedScott E Krahl, Shayani S Senanayake, Adrian Handforth
Journal of Neuroscience Research|January 25, 2011
C-terminal mechano-growth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase Cϵ/Nrf2 pathwayArnulfo Quesada, Julie Ogi, James Schultz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2008
The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradilPeter H Bui, Arnulfo Quesada, Adrian Handforth, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 30, 2023
Search for Novel Therapies for Essential Tremor Based on Positive Modulation of α6-Containing GABA<sub>A</sub> ReceptorsAdrian Handforth, Ram P Singh, Marco Treven, et al.
Epilepsia|August 5, 2006
Deep brain stimulation of the subthalamic nucleus as adjunct treatment for refractory epilepsyAdrian Handforth, Antonio A F DeSalles, Scott E Krahl
Clinical Neuropharmacology|September 15, 2010
A pilot efficacy and tolerability trial of memantine for essential tremorAdrian Handforth, Yvette Bordelon, Steven J Frucht, et al.
Brain Research. Developmental Brain Research|May 10, 2005
GABAA receptor beta3 subunit gene-deficient heterozygous mice show parent-of-origin and gender-related differences in beta3 subunit levels, EEG, and behaviorPatricia Liljelund, Adrian Handforth, Gregg E Homanics, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 8, 2018
Suppression of Harmaline Tremor by Activation of an Extrasynaptic GABA<sub>A</sub> Receptor: Implications for Essential TremorAdrian Handforth, Pournima A Kadam, Hovsep P Kosoyan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 2, 2009
Zonisamide for essential tremor: an evaluator-blinded studyAdrian Handforth, Fredricka C Martin, Gail A Kang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Harmaline-induced tremor as a potential preclinical screening method for essential tremor medicationsFredricka C Martin, Anh Thu Le, Adrian Handforth
Epilepsy Research|October 8, 2003
Right-sided vagus nerve stimulation reduces generalized seizure severity in rats as effectively as left-sidedScott E Krahl, Shayani S Senanayake, Adrian Handforth
Journal of Neuroscience Research|January 25, 2011
C-terminal mechano-growth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase Cϵ/Nrf2 pathwayArnulfo Quesada, Julie Ogi, James Schultz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2008
The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradilPeter H Bui, Arnulfo Quesada, Adrian Handforth, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 30, 2023
Search for Novel Therapies for Essential Tremor Based on Positive Modulation of α6-Containing GABA<sub>A</sub> ReceptorsAdrian Handforth, Ram P Singh, Marco Treven, et al.
Epilepsia|August 5, 2006
Deep brain stimulation of the subthalamic nucleus as adjunct treatment for refractory epilepsyAdrian Handforth, Antonio A F DeSalles, Scott E Krahl
Clinical Neuropharmacology|September 15, 2010
A pilot efficacy and tolerability trial of memantine for essential tremorAdrian Handforth, Yvette Bordelon, Steven J Frucht, et al.
Brain Research. Developmental Brain Research|May 10, 2005
GABAA receptor beta3 subunit gene-deficient heterozygous mice show parent-of-origin and gender-related differences in beta3 subunit levels, EEG, and behaviorPatricia Liljelund, Adrian Handforth, Gregg E Homanics, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 8, 2018
Suppression of Harmaline Tremor by Activation of an Extrasynaptic GABA<sub>A</sub> Receptor: Implications for Essential TremorAdrian Handforth, Pournima A Kadam, Hovsep P Kosoyan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 2, 2009
Zonisamide for essential tremor: an evaluator-blinded studyAdrian Handforth, Fredricka C Martin, Gail A Kang, et al.
Pageof 3